Vitamin D deficiency is common in psychogeriatric patients, independent of diagnosis

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Grønli, Ole ^a,b,c   Kvamme, Jan M ^a,b   Jorde, Rolf ^a,b   Wynn, Rolf ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c Department of Geriatric Psychiatry UNN Åsgård ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

AGED; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BODY MASS; COGNITION; CONTROLLED STUDY; CORNELL SCALE FOR DEPRESSION IN DEMENTIA; DEMENTIA; DEPRESSION; DIAGNOSIS RELATED GROUP; FEMALE; GERONTOPSYCHIATRY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; MINI MENTAL STATE EXAMINATION; PSYCHOSIS; SEASONAL VARIATION; SMOKING; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; BODY COMPOSITION; GERIATRIC ASSESSMENT; MENTAL DISORDERS; NEUROPSYCHOLOGICAL TEST; NORWAY; PREVALENCE; SEASON; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BODY COMPOSITION; BODY MASS INDEX; FEMALE; GERIATRIC ASSESSMENT; GERIATRIC PSYCHIATRY; HUMANS; MALE; MENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS; NORWAY; PREVALENCE; SEASONS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84900483095     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-14-134     Document Type: Article

References (65)

1. Sedrani SH. Low 25-hydroxyvitamin D and normal serum calcium concentrations in Saudi Arabia: Riyadh region. Ann Nutr Metab 1984, 28(3):181-185. 10.1159/000176801, 6610383.
2. McGrath JJ, Kimlin MG, Saha S, Eyles DW, Parisi AV. Vitamin D insufficiency in south-east Queensland. Med J Aust 2001, 174(3):150-151.
3. Marwaha RK, Tandon N, Reddy DR, Aggarwal R, Singh R, Sawhney RC, Saluja B, Ganie MA, Singh S. Vitamin D and bone mineral density status of healthy schoolchildren in northern India. Am J Clin Nutr 2005, 82(2):477-482.
4. Mai XM, Chen Y, Camargo CA, Langhammer A. Cross-sectional and prospective cohort study of serum 25-hydroxyvitamin D level and obesity in adults: the HUNT study. Am J Epidemiol 2012, 175(10):1029-1036. 10.1093/aje/kwr456, 22312120.
5. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008, 87(4):1080S-6S.
6. Holick MF. Vitamin D deficiency. N Engl J Med 2007, 357(3):266-281. 10.1056/NEJMra070553, 17634462.
7. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988, 67(2):373-378. 10.1210/jcem-67-2-373, 2839537.
8. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet 1989, 2(8671):1104-1105.
9. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001, 22(4):477-501. 10.1210/edrv.22.4.0437, 11493580.
10. Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, Knol DL, Lips P. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007, 92(6):2058-2065. 10.1210/jc.2006-1525, 17341569.
11. Institute of Medicine Dietary reference intakes for calcium and vitamin D 2011, Washington, DC: The National Academies Press, Institute of Medicine.
12. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006, 14(12):1032-1040. 10.1097/01.JGP.0000240986.74642.7c, 17138809.
13. Milaneschi Y, Shardell M, Corsi AM, Vazzana R, Bandinelli S, Guralnik JM, Ferrucci L. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab 2010, 95(7):3225-3233. 10.1210/jc.2010-0347, 2928895, 20444911.
14. Stewart R, Hirani V. Relationship between vitamin D levels and depressive symptoms in older residents from a national survey population. Psychosom Med 2010, 72(7):608-612. 10.1097/PSY.0b013e3181e9bf15, 20595420.
15. Lee DM, Tajar A, O'Neill TW, O'Connor DB, Bartfai G, Boonen S, Bouillon R, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Punab M, Silman AJ, Vanderschueren D, Wu FC, Pendleton N. EMAS study group: lower vitamin D levels are associated with depression among community-dwelling European men. J Psychopharmacol 2011, 25(10):1320-1328. 10.1177/0269881110379287, 20823081.
16. Kjaergaard M, Joakimsen R, Jorde R. Low serum 25-hydroxyvitamin D levels are associated with depression in an adult Norwegian population. Psychiatry Res 2011, 190(2-3):221-225.
17. Zhao G, Ford ES, Li C, Balluz LS. No associations between serum concentrations of 25-hydroxyvitamin D and parathyroid hormone and depression among US adults. Br J Nutr 2010, 104(11):1696-1702. 10.1017/S0007114510002588, 20642877.
18. Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry 2013, 202:100-107. 10.1192/bjp.bp.111.106666, 23377209.
19. Lansdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl) 1998, 135(4):319-323. 10.1007/s002130050517, 9539254.
20. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 2008, 264(6):599-609. 10.1111/j.1365-2796.2008.02008.x, 18793245.
21. Kjaergaard M, Waterloo K, Wang CE, Almas B, Figenschau Y, Hutchinson MS, Svartberg J, Jorde R. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry 2012, 201(5):360-368. 10.1192/bjp.bp.111.104349, 22790678.
22. Khoraminya N, Tehrani-Doost M, Jazayeri S, Hosseini A, Djazayery A. Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Aust N Z J Psychiatry 2013, 47(3):271-275. 10.1177/0004867412465022, 23093054.
23. Buell JS, Scott TM, Dawson-Hughes B, Dallal GE, Rosenberg IH, Folstein MF, Tucker KL. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 2009, 64(8):888-895. 2981461, 19377013.
24. Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, Allain P, Herrmann FR, Beauchet O. Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 2010, 74(1):27-32. 10.1212/WNL.0b013e3181beecd3, 19794127.
25. Llewellyn DJ, Lang IA, Langa KM, Melzer D. Vitamin D and cognitive impairment in the elderly U.S. population. J Gerontol A Biol Sci Med Sci 2011, 66(1):59-65. 3011960, 21041201.
26. Berg AO, Melle I, Torjesen PA, Lien L, Hauff E, Andreassen OA. A cross-sectional study of vitamin D deficiency among immigrants and Norwegians with psychosis compared to the general population. J Clin Psychiatry 2010, 71(12):1598-1604. 10.4088/JCP.09m05299yel, 20441728.
27. Hedelin M, Lof M, Olsson M, Lewander T, Nilsson B, Hultman CM, Weiderpass E. Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population. BMC Psychiatry 2010, 10:38. 244X-10-38, 10.1186/1471-244X-10-38, 2889879, 20504323.
28. Itzhaky D, Amital D, Gorden K, Bogomolni A, Arnson Y, Amital H. Low serum vitamin D concentrations in patients with schizophrenia. Isr Med Assoc J 2012, 14(2):88-92.
29. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The mini-international neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(20):22-33. quiz 34-57.
30. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389. 10.1192/bjp.134.4.382, 444788.
31. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12(3):189-198. 10.1016/0022-3956(75)90026-6, 1202204.
32. Shulman KI. Clock-drawing: is it the ideal cognitive screening test?. Int J Geriatr Psychiatry 2000, 15(6):548-561. 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U, 10861923.
33. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in Dementia. Biol Psychiatry 1988, 23(3):271-284. 10.1016/0006-3223(88)90038-8, 3337862.
34. Grimnes G, Almaas B, Eggen AE, Emaus N, Figenschau Y, Hopstock LA, Hutchinson MS, Methlie P, Mihailova A, Sneve M, Torjesen P, Wilsgaard T, Jorde R. Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol 2010, 163(2):339-348. 10.1530/EJE-10-0150, 20479012.
35. Pedersen R, Hofmann B, Mangset M. Patient autonomy and informed consent in clinical practice. Tidsskr Nor Laegeforen 2007, 127(12):1644-1647.
36. van der Wielen RP, Lowik MR, van den Berg H, de Groot LC, Haller J, Moreiras O, van Staveren WA. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995, 346(8969):207-210. 10.1016/S0140-6736(95)91266-5, 7616799.
37. Lapid MI, Drake MT, Geske JR, Mundis CB, Hegard TL, Kung S, Frye MA. Hypovitaminosis D in psychogeriatric inpatients. J Nutr Health Aging 2013, 17(3):231-234. 10.1007/s12603-012-0383-7, 23459975.
38. Schneider B, Weber B, Frensch A, Stein J, Fritz J. Vitamin D in schizophrenia, major depression and alcoholism. J Neural Transm 2000, 107(7):839-842. 10.1007/s007020070063, 11005548.
39. Humble MB, Gustafsson S, Bejerot S. Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis. J Steroid Biochem Mol Biol 2010, 121(1-2):467-470.
40. Stern RA, Robinson B, Thorner AR, Arruda JE, Prohaska ML, Prange AJ. A survey study of neuropsychiatric complaints in patients with graves' disease. J Neuropsychiatry Clin Neurosci 1996, 8(2):181-185.
41. Chan AK, Duh QY, Katz MH, Siperstein AE, Clark OH. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy: a case-control study. Ann Surg 1995, 222(3):402-12. discussion 412-4, 10.1097/00000658-199509000-00017, 1234827, 7677469.
42. Lachner C, Steinle NI, Regenold WT. The neuropsychiatry of vitamin B12 deficiency in elderly patients. J Neuropsychiatry Clin Neurosci 2012, 24(1):5-15.
43. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005, 29(1):21-30. 10.1016/j.jchemneu.2004.08.006, 15589699.
44. Eyles DW, Burne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 2013, 34(1):47-64. 10.1016/j.yfrne.2012.07.001, 22796576.
45. Carlsson A. A half-century of neurotransmitter research: impact on neurology and psychiatry (Nobel lecture). Chembiochem 2001, 2(7-8):484-493.
46. Groves NJ, Kesby JP, Eyles DW, McGrath JJ, Mackay-Sim A, Burne TH. Adult vitamin D deficiency leads to behavioural and brain neurochemical alterations in C57BL/6 J and BALB/c mice. Behav Brain Res 2013, 241:120-131.
47. Lewis DA, Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 2006, 63(10):1372-1376. 10.1001/archneur.63.10.1372, 17030651.
48. Riaza Bermudo-Soriano C, Perez-Rodriguez MM, Vaquero-Lorenzo C, Baca-Garcia E. New perspectives in glutamate and anxiety. Pharmacol Biochem Behav 2012, 100(4):752-774. 10.1016/j.pbb.2011.04.010, 21569789.
49. Mohler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 2012, 62(1):42-53. 10.1016/j.neuropharm.2011.08.040, 21889518.
50. Szakacs R, Janka Z, Kalman J. The " blue" side of glutamatergic neurotransmission: NMDA receptor antagonists as possible novel therapeutics for major depression. Neuropsychopharmacol Hung 2012, 14(1):29-40.
51. Coyle JT. Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms. Neurotox Res 2006, 10(3-4):221-233.
52. Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008, 65(5):508-512. 10.1001/archpsyc.65.5.508, 18458202.
53. Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels: the Tromso study. J Neurol 2006, 253(4):464-470. 10.1007/s00415-005-0027-5, 16283099.
54. Gronli O, Wynn R. Normocalcemic hyperparathyroidism and treatment resistant depression. Psychosomatics 2013, 54:492-497.
55. Duque G, Close JJ, de Jager JP, Ebeling PR, Inderjeeth C, Lord S, McLachlan AJ, Reid IR, Troen BR, Sambrook PN. Treatment for osteoporosis in Australian residential aged care facilities: consensus recommendations for fracture prevention. Med J Aust 2010, 193(3):173-179.
56. Michael YL, Whitlock EP, Lin JS, Fu R, O'Connor EA, Gold R. US preventive services task force: primary care-relevant interventions to prevent falling in older adults: a systematic evidence review for the U.S preventive services task force. Ann Intern Med 2010, 153(12):815-825. 10.7326/0003-4819-153-12-201012210-00008, 21173416.
57. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007, 370(9588):657-666. 10.1016/S0140-6736(07)61342-7, 17720017.
58. Bischoff-Ferrari HA. Relevance of vitamin D in muscle health. Rev Endocr Metab Disord 2012, 13(1):71-77. 10.1007/s11154-011-9200-6, 22020957.
59. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 2009, 20(2):315-322. 10.1007/s00198-008-0662-7, 18629569.
60. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009, 339:b3692. 10.1136/bmj.b3692, 2755728, 19797342.
61. Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A. Vitamin D, nervous system and aging. Psychoneuroendocrinology 2009, 34(Suppl 1):S278-86.
62. de Abreu DA F, Eyles D, Feron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009, 34(1):S265-77.
63. Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromso study. Eur J Endocrinol 2010, 162(5):935-942. 10.1530/EJE-09-1041, 20185562.
64. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014, 2(1):76-89. 10.1016/S2213-8587(13)70165-7, 24622671.
65. Hansen V, Jacobsen BK, Arnesen E. Prevalence of serious psychiatric morbidity in attenders and nonattenders to a health survey of a general population: the Tromso health study. Am J Epidemiol 2001, 154(10):891-894. 10.1093/aje/154.10.891, 11700242.